At this time, posts about Yuhan Corporation are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 25,700 shares of Yuhan Corporation, and institutions have net purchased 20,000 shares. Yuhan Corporation is known as a leading domestic pharmaceutical company specializing in prescription drugs.


As of 1:31 PM on the 20th, Yuhan Corporation's stock price is 73,700 KRW, up 1.52% from the previous day, with a trading volume of 512,226 shares, which is 44.85% of the 5-day average trading volume. On January 19, Yuhan Corporation became a market issue with the news "'Lung cancer treatment' approved by the Ministry of Food and Drug Safety... 2% rise."


In addition to Yuhan Corporation, posts by investors are also rapidly increasing for iMBC (052220), SY (109610), and NanoCamtech (091970).



※ Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing